On April 24th, we invited you and other Canadian researchers to participate in a survey focused on selection criteria for central IRBs/REBs in Canada.

The response we received was impressive.  The analysis has been completed and we would like to share the results of this unique and important survey with you.

Simply click on the link below to download a copy of the detailed report to discover what Canadian researchers think about accreditation, cultural diversity, and Canadian ownership and management of a central IRB/REB.

We trust that the findings contained in the report will be of value to you, and invite you to share the report with your colleagues.

Dr. Janice Parente
Dr. Janice Parente

Janice completed both her PhD and Post-Doctoral Fellowship in Molecular Pharmacology, and proceeded to develop her skills at the Director level within global pharma before founding her first contract research organization (CRO) in 1992. During the ensuing decade, Janice established her credentials as a successful and respected business leader and entrepreneur. In 2002, she sold her company in order to found ethica Clinical Research Inc., instilling in it her values and commitment to the protection of human research participants. This commitment led to ethica becoming the first Canadian entity and the first CRO in the world to earn full accreditation of its Human Research Protection Program (HRPP) in 2006. Janice's leadership and entrepreneurship have been recognized through numerous awards and nominations such as the prestigious Ernst & Young and Bank of Montreal Entrepreneur of the Year Awards and PROFIT Magazine's PROFIT W100 ranking of Canada's Top Women Entrepreneurs.